No­vo Nordisk touts ex­pan­sion in Boston, cuts about 100 jobs in two oth­er US cities

No­vo Nordisk is ex­pand­ing its R&D and lab-based ac­tiv­i­ties in Boston while adding jobs — and cut­ting some else­where, too.

The com­pa­ny an­nounced to­day it’s adding more than 200 new jobs, with about 150 of them fo­cused on da­ta sci­ence, bi­ol­o­gy or chem­istry re­search and ri­bonu­cle­ic acid in­ter­fer­ence (RNAi) R&D in Lex­ing­ton, Cam­bridge and Wa­ter­town, MA.

But now that Boston will be the “prin­ci­pal” R&D site in the US, about 20 po­si­tions in In­di­anapo­lis and 80 po­si­tions in Seat­tle will be cut as lab-based work in Seat­tle is moved to oth­er lo­ca­tions glob­al­ly and clos­er to the R&D fa­cil­i­ty in In­di­anapo­lis.

To read Endpoints News become a free subscriber

Unlock this article instantly, along with access to limited free monthly articles and our suite of newsletters

SIGN UP LOG IN